Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lostam BioPharmaceuticals

Lostam BioPharmaceuticals
Out of Business LATEST DEAL TYPE

Developer of protein therapeutics designed to prevent and treat lethal Gram-negative bacterial infections. The company's protein therapeutics offers a panel of human therapeutic protein candidates and novel pipelines of anti-bacterial drugs capable of combating serious bacterial infections and of withstanding the cunning efforts of bacteria to develop drug-resistant mechanisms, enabling doctors to treat and prevent lethal Gram-negative bacterial infections associated primarily within the hospital setting.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Nazareth Industrial Area
  • PO Box 2252
  • Nazareth 16000
  • Israel
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lostam BioPharmaceuticals’s full profile, request a free trial.

Lostam BioPharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jul-2017 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Lostam BioPharmaceuticals Executive Team (1)

Name Title Board
Lewis Neville Ph.D Founder, Chief Technology Officer & Chief Executive Officer